High efficiency diffusion molecular retention tumor targeting.

Area of Science:

• Biomedical Engineering
• Molecular Imaging
• Oncology

Background:

• Targeted tumor delivery of imaging and therapeutic agents remains a challenge.
• Current methods often suffer from low specificity and require high doses.
• Integrin-mediated molecular recognition offers a potential mechanism for selective tumor retention.

Purpose of the Study:

• To introduce and validate Diffusion Molecular Retention (DMR) as a novel tumor targeting strategy.
• To assess the efficacy of DMR for delivering probes via peritumoral injection.
• To compare DMR targeting with traditional intravenous delivery methods.

Main Methods:

• Synthesis of PEG-fluorochrome shielded probes (RGD for integrin binding, RAD as control) with DOTA for (111)In labeling.
• Peritumoral (PT) and intravenous (IV) administration of probes in a GFP-BT-20 breast carcinoma model.
• Assessment using surface fluorescence, SPECT imaging, and biodistribution studies.

Main Results:

• PT injected probes diffused extensively through tumor and normal tissue interstitium.
• RGD probes showed selective retention in tumors via integrin interactions.
• DMR achieved significantly higher tumor uptake (352%ID/g) compared to IV injection (4.14%ID/g) at 24 hours post-injection.

Conclusions:

• DMR enables highly efficient and tumor-specific molecular targeting through PT injection and integrin recognition.
• The method utilizes low probe doses, minimizing toxicity and facilitating clinical translation.
• DMR has broad applications in delivering imaging agents, radioisotopes for radiotherapy, and photosensitizers.